Khurram Jamil, Chief Medical Officer: Galectin Therapeutics GALT Sell · Filed 25/11/14

Trade details

Type: Insider sale
Amount: $227,005
Shares · price: 41,500 sh · $5.47 a share
Held after: 4,479 sh
Stock: Galectin Therapeutics GALT
Person: Khurram JamilChief Medical Officer
Trade date: 25/11/13
Filed: 25/11/14
Days to filing: 1 days

Sold 90.3% of holdings

Share of holding sold: 90.3%

Galectin Therapeutics trades, last 26 weeks

What else happened in Galectin Therapeutics around then

Filed or reported within 30 days of the trade day · 25/10/14~25/12/13

Khurram Jamil's recent trades

Khurram JamilChief Medical Officer
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$239.2K
47,467 sh
$239.2K
Filed 06/30
Traded 06/29
Khurram JamilChief Medical Officer
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$12.7K
2,533 sh
$12.7K
Filed 06/30
Traded 06/26
Khurram JamilChief Medical Officer
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$10.2K
2,037 sh
$10.2K
Filed 06/30
Traded 06/26
Khurram JamilChief Medical Officer
Planned sale10b5-1 planGalectin Therapeutics
Planned sale10b5-1 plan
Galectin Therapeutics
GALT
$341.4K
68,287 sh
$341.4K
Filed 06/26
Traded 06/26
Khurram JamilChief Medical Officer
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$23.7K
7,557 sh
$23.7K
Filed 06/25
Traded 06/23

Khurram Jamil, Chief Officer — sold $227K of Galectin Therapeutics GALT · 90.3% of holdings · 10b5-1 plan | Whalegun